| No |
Title |
Sources |
Date of
Registration |
Views |
| 1 |
Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent rhPSMA-7.3 (18F) in Collaboration with Nucleis
|
businesswire |
2021-01-07 |
1 |
| 2 |
Rosatom First Delivered the Radioisotope Lutetium-177 to a Medical Facility in Europe
|
GMP News |
2021-01-07 |
1 |
| 3 |
IBA selected to Equip IRE’s new Radioisotope Production Unit Dedicated to Cancer Diagnosis
|
IBA Radiopharma Solutions |
2021-01-07 |
1 |
| 4 |
Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Report 2020-2030: Current Market Landscape and Potential of C
|
Research and Markets |
2021-01-07 |
1 |
| 5 |
Bruce Power and IsoGen set a first critical milestone for the exclusive irradiation service provided to ITM for its prod
|
Business Wire |
2021-01-07 |
1 |
| 6 |
New Imaging Agent Spotlights Inflammation
|
Imaging Research |
2021-01-07 |
1 |
| 7 |
BWXT Peterborough Touts ‘Tremendous Progress’ in Medical Isotope Production at Darlington Nuclear Station
|
Global News |
2021-01-07 |
1 |
| 8 |
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
|
RadioMedix |
2021-01-07 |
1 |
| 9 |
Radioisotope Power Systems for Future Missions may Benefit from ORNL Simulations
|
Oak Ridge National Laboratory |
2021-01-07 |
1 |
| 10 |
New Nanoparticles Hold Promise for Radiopharmaceuticals Efficiency
|
IAEA |
2021-01-07 |
1 |
CUSTOMER CENTER
